The primary objective of this registry is to capture real-world safety and performance data on AtriCure devices used to ablate cardiac tissue when treating Inappropriate Sinus Tachycardia (IST) or Postural Tachycardia Syndrome (POTS). This is a retrospective and prospective, multicenter, US/OUS, observational data registry.
Study Type
OBSERVATIONAL
Enrollment
500
Epicardial and endocardial hybrid ablation procedure used to treat the IST or POTS using AtriCure commercially available devices.
Stanford University
Palo Alto, California, United States
RECRUITINGSequoia Hospital
Redwood City, California, United States
RECRUITINGAtriCure commercially available devices used to treat IST or POTS
The IST Registry will attempt to enroll all eligible patients at registry sites who have already had or are scheduled to have a procedure to treat IST/POTS that includes the use of at least one commercially available AtriCure cardiac ablation devices.
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
University of Florida
Gainesville, Florida, United States
RECRUITINGSarasota Memorial Hospital
Sarasota, Florida, United States
RECRUITINGKansas City Cardiac Arrhythmia Research
Kansas City, Kansas, United States
RECRUITINGMedStar Health Research Institute
Hyattsville, Maryland, United States
RECRUITINGThe Carl & Edyth Lindner Center for Research & Education at The Christ Hospital
Cincinnati, Ohio, United States
RECRUITINGTexas Cardiac Arrhythmia Research Foundation
Austin, Texas, United States
RECRUITINGIntermountain Medical Center
Murray, Utah, United States
RECRUITINGUniversitair Ziekenhuis Brussels
Brussels, Belgium
RECRUITING